Having tried several botulinum toxin products in the past, I was particularly interested in seeing how Letybo would compare, especially since it’s a newer option recently approved by the FDA in 2024. One aspect that stood out to me was the way the results settled over the first five days — the progression felt smooth and natural, without the stiffness or frozen look some other treatments caused. From Day 1, I noticed the initial effects starting to develop, with subtle softening of the frown lines. By Day 4, the line reduction was visibly noticeable but still allowed my face to express emotions naturally. This balance is crucial because the goal is enhancement rather than looking overdone. On Day 5, my skin appeared refreshed and relaxed in the brow area, which made me feel more confident. Having my treatment done by a trusted injector was key; their expertise ensures that the dosage and injection points are customized to my facial anatomy, maximizing results and minimizing side effects. Letybo’s origin from South Korea, a leader in innovative skincare and aesthetic treatments, adds to its appeal. It’s also reassuring that it’s FDA-approved, confirming its safety and efficacy for use in the U.S. For anyone considering botulinum toxin treatments for frown lines, I’d recommend researching Letybo along with other options. It’s important to understand that individual results and timing can vary based on factors like skin type, muscle strength, and treatment area. Documenting the first few days after treatment helps track changes and communicate with your injector for adjustments if needed. Overall, my experience with Letybo has been very positive. The treatment delivered noticeable wrinkle softening while keeping a natural appearance, enhancing my confidence without making me feel like I lost my expressions. I look forward to seeing how long the effects last and will keep sharing updates for those curious about this new aesthetic option.